Clinical trial
Comparison of Short- and Medium- Term Efficacy of Patent Foramen Ovale Closure and Medication in the Treatment of Migraine
NCT06192173 is registered in ClinicalTrials.gov with Haiyan Wang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Short- and Medium- Term Efficacy of Patent Foramen Ovale Closure and Medication in the Treatment of Migraine
- Lead sponsor
- Haiyan Wang
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 5, 2022
- Completion date
- May 20, 2023
- Enrollment
- 138 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine, patent foramen ovale